Polyphor In Peril After Breast Cancer Drug Failure

Shares Crash On Balixafortide Setback

 
• By Kevin Grogan
  
Swiss wallet
Money is tight at troubled Swiss biotech Polyphor • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas